Luyan Pharma Co.,Ltd. (SHE:002788)
China
· Delayed Price · Currency is CNY 15.04
+0.23 (1.55%)
Mar 10, 2026, 12:55 PM CST
Luyan Pharma Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,754 | 3,190 | 3,493 | 3,236 | 3,034 | 3,081 | Upgrade
|
| Market Cap Growth | 78.65% | -8.68% | 7.92% | 6.66% | -1.51% | 15.67% | Upgrade
|
| Enterprise Value | 10,323 | 7,860 | 8,216 | 7,721 | 7,052 | 6,338 | Upgrade
|
| Last Close Price | 14.81 | 7.88 | 8.31 | 7.45 | 6.74 | 6.68 | Upgrade
|
| PE Ratio | 18.51 | 9.23 | 9.61 | 9.38 | 9.92 | 11.56 | Upgrade
|
| PS Ratio | 0.28 | 0.16 | 0.18 | 0.17 | 0.17 | 0.20 | Upgrade
|
| PB Ratio | 1.76 | 1.00 | 1.17 | 1.16 | 1.19 | 1.26 | Upgrade
|
| P/TBV Ratio | 2.22 | 1.27 | 1.52 | 1.44 | 1.49 | 1.55 | Upgrade
|
| P/FCF Ratio | 17.04 | 14.74 | 4.48 | - | - | - | Upgrade
|
| P/OCF Ratio | 9.44 | 5.52 | 2.67 | 13.94 | - | 51.01 | Upgrade
|
| EV/Sales Ratio | 0.49 | 0.38 | 0.41 | 0.40 | 0.40 | 0.41 | Upgrade
|
| EV/EBITDA Ratio | 13.67 | 10.47 | 10.90 | 10.19 | 10.77 | 10.59 | Upgrade
|
| EV/EBIT Ratio | 16.65 | 11.49 | 11.82 | 10.99 | 11.75 | 11.52 | Upgrade
|
| EV/FCF Ratio | 30.58 | 36.33 | 10.54 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.53 | 1.55 | 1.63 | 1.82 | 1.75 | 1.43 | Upgrade
|
| Debt / EBITDA Ratio | 6.63 | 6.09 | 5.96 | 6.23 | 6.29 | 5.85 | Upgrade
|
| Debt / FCF Ratio | 14.82 | 22.88 | 6.23 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 1.39 | 1.37 | 1.43 | 1.61 | 1.59 | 1.19 | Upgrade
|
| Net Debt / EBITDA Ratio | 6.57 | 5.83 | 5.64 | 5.92 | 6.22 | 4.85 | Upgrade
|
| Net Debt / FCF Ratio | 13.46 | 20.22 | 5.45 | -47.03 | -6.61 | -26.31 | Upgrade
|
| Asset Turnover | 1.64 | 1.68 | 1.68 | 1.79 | 1.89 | 1.93 | Upgrade
|
| Inventory Turnover | 7.09 | 6.97 | 7.16 | 7.44 | 7.52 | 7.56 | Upgrade
|
| Quick Ratio | 0.77 | 0.77 | 0.79 | 0.79 | 0.80 | 0.81 | Upgrade
|
| Current Ratio | 1.10 | 1.15 | 1.16 | 1.17 | 1.19 | 1.22 | Upgrade
|
| Return on Equity (ROE) | 9.69% | 11.27% | 12.64% | 13.12% | 12.17% | 12.31% | Upgrade
|
| Return on Assets (ROA) | 3.05% | 3.50% | 3.68% | 4.03% | 4.04% | 4.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.06% | 7.10% | 7.44% | 7.61% | 7.35% | 7.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.40% | 17.00% | 18.40% | 20.20% | 20.20% | 20.70% | Upgrade
|
| Earnings Yield | 5.35% | 10.84% | 10.41% | 10.66% | 10.08% | 8.65% | Upgrade
|
| FCF Yield | 5.87% | 6.78% | 22.33% | -2.95% | -20.29% | -3.58% | Upgrade
|
| Dividend Yield | 2.33% | 4.44% | 3.61% | 4.03% | 4.45% | 2.99% | Upgrade
|
| Payout Ratio | 106.59% | 93.69% | 93.56% | 95.92% | 81.76% | 79.93% | Upgrade
|
| Buyback Yield / Dilution | 0.25% | -0.42% | 0.28% | -0.17% | -7.46% | -9.83% | Upgrade
|
| Total Shareholder Return | 2.58% | 4.02% | 3.89% | 3.86% | -3.00% | -6.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.